Suppr超能文献

参与阿尔茨海默病、tau蛋白病及APP转基因小鼠中tau蛋白磷酸化的应激激酶。

Stress kinases involved in tau phosphorylation in Alzheimer's disease, tauopathies and APP transgenic mice.

作者信息

Ferrer I

机构信息

Institut de Neuropatologia, Servei Anatomia Patològica, Hospital de Bellvitge, Universitat de Barcelona, Hospitalet de Llobregat, Spain.

出版信息

Neurotox Res. 2004;6(6):469-75. doi: 10.1007/BF03033283.

Abstract

Hyperphosphorylation and accumulation of tau in neurons (and glial cells) is one of the main pathologic hallmarks in Alzheimer's disease (AD) and other tauopathies, including Pick's disease (PiD), progressive supranuclear palsy, corticobasal degeneration, argyrophilic grain disease and familial frontotemporal dementia and parkinsonism linked to chromosome 17 due to mutations in the tau gene (FTDP-17-tau). Recent studies have shown increased expression of select active kinases, including stress-activated kinase, c-Jun N-terminal kinase (SAPK/JNK) and kinase p38 in brain homogenates in all the tauopathies. Strong active SAPK/JNK and p38 immunoreactivity has been observed restricted to neurons and glial cells containing hyperphosphorylated tau, as well as in dystrophic neurites of senile plaques in AD. Moreover, SAPK/JNK- and p38-immunoprecipitated sub-cellular fractions enriched in abnormal hyperphosphorylated tau have the capacity to phosphorylate recombinat tau and c-Jun and ATF-2 which are specific substrates of SAPK/JNK and p38 in AD and PiD. Interestingly, increased expression of phosphorylated SAPK/JNK and p38 in association with hyperphosphorylated tau containing neurites have been observed around betaA4 amyloid deposits in the brain of transgenic mice (Tg2576)carrying the double APP Swedish mutation. These findings suggest that betaA4 amyloid has the capacity to trigger the activation of stress kinases which, in turn, phosphorylate tau in neurites surrounding amyloid deposits. Reduction in the amyloid burden and decreased numbers of amyloid plaques but not of neurofibrillary degeneration has been observed in the brain of two AD patients who participated in an amyloid-beta immunization trial. Activation of stress kinases SAPK/JNK and p38 were reduced together with decreased tau hyperphosphorylation of aberrant neurites in association with decreased amyloid plaques. These findings support the amyloid cascade hypothesis of tau phosphorylation mediated by stress kinases in dystrophic neurites of senile plaques but not that of neurofibrillary tangles and neuropil threads in AD.

摘要

tau蛋白在神经元(和神经胶质细胞)中的过度磷酸化和积聚是阿尔茨海默病(AD)及其他tau蛋白病的主要病理特征之一,这些tau蛋白病包括匹克氏病(PiD)、进行性核上性麻痹、皮质基底节变性、嗜银颗粒病以及因tau基因突变导致的与17号染色体相关的家族性额颞叶痴呆和帕金森综合征(FTDP-17-tau)。最近的研究表明,在所有tau蛋白病的脑匀浆中,包括应激激活激酶、c-Jun氨基末端激酶(SAPK/JNK)和p38激酶在内的特定活性激酶的表达均增加。已观察到强烈的活性SAPK/JNK和p38免疫反应性局限于含有过度磷酸化tau蛋白的神经元和神经胶质细胞,以及AD患者老年斑的营养不良性神经突中。此外,富含异常过度磷酸化tau蛋白的SAPK/JNK和p38免疫沉淀亚细胞组分具有磷酸化重组tau蛋白以及c-Jun和ATF-2的能力,而c-Jun和ATF-2是AD和PiD中SAPK/JNK和p38的特异性底物。有趣的是,在携带双APP瑞典突变的转基因小鼠(Tg2576)大脑中,已观察到与含有过度磷酸化tau蛋白的神经突相关的磷酸化SAPK/JNK和p38表达增加,且这些神经突周围存在βA4淀粉样蛋白沉积。这些发现表明,βA4淀粉样蛋白能够触发应激激酶的激活,进而使淀粉样蛋白沉积周围神经突中的tau蛋白磷酸化。在参与淀粉样β免疫试验的两名AD患者大脑中,已观察到淀粉样蛋白负荷降低以及淀粉样斑块数量减少,但神经原纤维变性未减少。应激激酶SAPK/JNK和p38的激活减少,同时异常神经突中tau蛋白的过度磷酸化也减少,且淀粉样斑块数量减少。这些发现支持了应激激酶介导的tau蛋白磷酸化的淀粉样蛋白级联假说,该假说适用于老年斑的营养不良性神经突,但不适用于AD中的神经原纤维缠结和神经毡丝。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验